华森制药（002907.SZ）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

私营企业39.04%
个人与内部人士30.68%
公众及其他27.50%
机构投资者2.77%

主要股东

主要股东最新
股东
Zhuhai Weilinsi New Material Development Co., Ltd.	39.04%	1.63 亿	0.00%	+0	2026/03/31
Hongtao YouChairman of the Board	15.91%	6,645.60 万	0.40%	-166.50 万	2026/03/31
Ying WangHead of Phramaceutical Sales, Deputy GM & Director	8.76%	3,660.00 万	0.00%	+0	2026/03/31
Xiaoying LiuCEO, GM & Director	6.00%	2,506.28 万	1.71%	-715.00 万	2026/06/12
Shanghai Tiancheng Investment Management Co., Ltd.	1.07%	444.85 万	0.21%	-88.87 万	2026/03/31
Hong Kong Exchanges and Clearing Limited	0.52%	217.74 万	0.02%	+9.95 万	2026/03/31
Dajia Asset Management Co., Ltd.	0.38%	160.00 万	0.00%	+0	2025/03/31
The Goldman Sachs Group, Inc.	0.25%	103.07 万	0.13%	+56.07 万	2026/03/31
Vanguard Capital Management, LLC	0.20%	84.11 万	0.00%	+0	2026/06/30
Morgan Stanley	0.13%	53.66 万	0.00%	+0	2024/12/31
Penghua Fund Management Co., Ltd.	0.10%	43.62 万	0.00%	+0	2025/12/31
Dimensional Fund Advisors LP	0.06%	23.36 万	<0.01%	-1.25 万	2026/06/30
Vanguard Fiduciary Trust Company	0.05%	21.77 万	<0.01%	+2,600.00	2026/06/30
Yinhua Fund Management Co., Ltd.	<0.01%	2.41 万	0.00%	+0	2025/12/31
Xiaoyan PengAccounting Supervisor & CFO	<0.01%	1.32 万	0.00%	+0	2025/12/31
Wanjia Asset Management Co., Ltd.	<0.01%	1.19 万	0.00%	+0	2025/12/31
Huatai-PineBridge Fund Management Co., Ltd.	<0.01%	1.13 万	0.00%	+0	2025/06/30
China Fund Management Co., Ltd.	<0.01%	300.00	0.00%	+0	2025/06/30
Ping An UOB Fund Management Co., Ltd.	<0.01%	200.00	0.00%	+0	2025/12/31
Zhichun DengFormer Supervisor	<0.01%	100.00	0.00%	+0	2024/12/31